Understanding Clinical Trial Terminology: What's a Phase 1, 2 or 3 Clinical Trial? - Concert Pharmaceuticals
An FDA Viewpoint on Unique Considerations for Medical-Device Clinical Trials | NEJM
Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis | The BMJ
Will Canada's Multi-Center Approval Processes Help Your Oncology Clinical Trial Exceed Pivotal Milestones? - Scimega
REACH-CDM Trial Begins for AMO-02 in Steinert Disease
Artificial Intelligence for Clinical Trial Design: Trends in Pharmacological Sciences